LINCOLN PHARMACEUTICALS
Back to Balance Sheet
|
LINCOLN PHARMACEUTICALS Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹472 Cr | ₹394 Cr | ₹346 Cr | ₹295 Cr | ₹262 Cr |
What is the latest Net Current Assets ratio of LINCOLN PHARMACEUTICALS ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹472 Cr |
| Mar2025 | ₹394 Cr |
| Mar2024 | ₹346 Cr |
| Mar2023 | ₹295 Cr |
| Mar2022 | ₹262 Cr |
How is Net Current Assets of LINCOLN PHARMACEUTICALS Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹472 Cr | 19.88 | |
| Mar2025 | ₹394 Cr | 13.96 | |
| Mar2024 | ₹346 Cr | 17.09 | |
| Mar2023 | ₹295 Cr | 12.47 | |
| Mar2022 | ₹262 Cr | - | |
Compare Net Current Assets of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹1,044.0 Cr | 1.5% | -4% | -0.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,291.0 Cr | -1.8% | 7.6% | 11.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹305,014.0 Cr | 3.7% | 27.2% | 71.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,333.0 Cr | -2.3% | 1.5% | 23.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,017.0 Cr | 0.6% | 13.4% | 15.7% | Stock Analytics | |
| CIPLA | ₹112,539.0 Cr | -1.3% | 6.1% | -6.9% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | 1.5% |
-4% |
-0.6% |
| SENSEX | 0.7% |
11.7% |
-2% |
You may also like the below Video Courses